CIWA-Ar breaks down when patients can’t participate. mMINDS offers an objective, ICU-ready approach to scoring severe alcohol withdrawal—especially in delirious, intubated, or critically ill patients.
The post MDCalc Wars: Alcohol Withdrawal–When CIWA-Ar Breaks Down, mMINDS Score Still Works appeared first on REBEL EM – Emergency Medicine Blog.
Alcohol withdrawal syndrome is a serious condition that requires careful assessment and management to prevent complications such as delirium tremens and seizures. The Clinical Institute Withdrawal Assessment for Alcohol revised, or CIWA-Ar, is a commonly used 10-item scale that evaluates symptoms like nausea, tremor, anxiety, and hallucinations. While it is widely used, CIWA-Ar has significant limitations. It relies on subjective patient reporting, making it difficult to use in patients who are intubated, sedated, or have altered mental status due to other medical conditions such as head trauma, stroke, or sepsis. Its scores can be falsely elevated by other medical issues, potentially leading to inappropriate treatment.
The Minnesota Intoxication Management and Delirium tremens Scale, or MMINDS, is presented as an alternative 5-item tool for assessing alcohol withdrawal, especially in critically ill patients. MMINDS focuses on objective signs, including tremor, sweating, orientation, agitation, and hallucinations. This objective approach allows for more reliable assessment in patients who cannot verbally communicate. A score of four or higher on MMINDS suggests alcohol withdrawal. This scale helps to guide treatment decisions, with higher scores indicating a need for more aggressive therapy.
Treatment for alcohol withdrawal syndrome often involves benzodiazepines. The content suggests phenobarbital as an effective front-line agent, particularly in severe withdrawal or when benzodiazepines are insufficient, due to its long duration of action and anticonvulsant properties. Other medications like propofol are mentioned for refractory cases, typically in intensive care settings, and dexmedetomidine for sedation. Adjunctive therapies such as valproic acid or gabapentin are also noted in the comprehensive management of alcohol withdrawal syndrome.
https://rebelem.com/mdcalc-wars-alcohol-withdrawal-when-ciwa-ar-breaks-down-mminds-score-still-works/?utm_source=rss&utm_medium=rss&utm_campaign=mdcalc-wars-alcohol-withdrawal-when-ciwa-ar-breaks-down-mminds-score-still-works
